Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...

OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...

Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and ...

For centuries, extinction has meant the end—but what if it didn’t have to? Using advanced genetic engineering, a handful of biotech companies are working to bring extinct species back to life, from ...

ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101  BERLIN, Germany and BRUSSELS, Belgium, December 09, 2025 / Biotech ...

The National Academy of Inventors (NAI) today released the list of newly inducted fellows, and two Duke researchers have been ...

Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically ...

The National Academy of Inventors (NAI) today released the list of newly inducted fellows, and two Duke researchers have been ...

Their data suggests that tweaking the expression of FDX2 could make up for the loss of frataxin, the protein tied to FA's development.

STEM-engineered CAR T cells performed as well as or better against cancer cells than did FDA-approved CAR T cells and kept their cancer-fighting abilities for longer.

Lamm, a serial entrepreneur, co-founded the Dallas-based biotech firm in 2021 alongside Harvard geneticist George Church to ...

In a new study published in Nature, scientists have successfully developed genetically modified mosquitoes in Tanzania that ...